Skip to main content
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1981 Oct;12(4):543–548. doi: 10.1111/j.1365-2125.1981.tb01263.x

The distribution of propranolol, pindolol and atenolol between human erythrocytes and plasma.

E A Taylor, P Turner
PMCID: PMC1401913  PMID: 7295488

Abstract

1 This study aimed (1) to measure the whole blood to plasma (WB:P) and red blood cell to plasma (RBC:P) concentration ratios of propranolol in healthy volunteers and two types of patients, and (2) to compare the concentration ratios of the lipophilic drug propranolol with moderately lipophilic pindolol and hydrophilic atenolol. 2 There was no significant difference between the WB:P and RBC:P ratios of propranolol concentration in healthy volunteers and neurological patients compared with hypertensive patients. The mean +/- s.d. WB:P ratios of propranolol concentration in the three groups were 0.74 +/- 0.03, 0.71 +/- 0.05, and 0.76 +/- 0.08 respectively. The mean RBC:P ratios were 0.39 +/- 0.08, 0.36 +/- 0.11, and 0.47 +/- 0.15 respectively. WB:P and RBC:P concentration ratios of propranolol were linearly correlated with the free fraction of drug in plasma. Propranolol was 90% bound in plasma. 3 The mean WB:P and RBC:P ratios of pindolol in seven volunteers were 0.69 +/- 0.08 and 0.37 +/- 0.14 respectively. Pindolol was 71.4 +/- 8.6% bound to plasma proteins. The concentration of pindolol in the RBC was linearly correlated with that unbound in plasma. 4 In four healthy volunteers, the mean WB:P concentration ratio of atenolol was 1.07 +/- 0.25 and the mean RBC:P ratio was 1.15 +/- 0.55. 5 The similarity of the RBC:free plasma drug concentration ratios for all three drugs suggests that the use of organic solvent partition coefficients for the prediction of in vivo distribution may be unreliable.

Full text

PDF
543

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Barber H. E., Hawksworth G. M., Kitteringham N. R., Petersen J., Petrie J. C., Swann J. M. Protein binding of atenolol and propranolol to human serum albumin and in human plasma [proceedings]. Br J Clin Pharmacol. 1978 Nov;6(5):446P–447P. [PubMed] [Google Scholar]
  2. Beermann B., Groschinsky-Grind M., Rosén A. Absorption, metabolism, and excretion of hydrochlorothiazide. Clin Pharmacol Ther. 1976 May;19(5 Pt 1):531–537. doi: 10.1002/cpt1976195part1531. [DOI] [PubMed] [Google Scholar]
  3. Beermann B., Hellström K., Lindström B., Rosén A. Binding-site interaction of chlorthalidone and acetazolamide, two drugs transported by red blood cells. Clin Pharmacol Ther. 1975 Apr;17(4):424–432. doi: 10.1002/cpt1975174424. [DOI] [PubMed] [Google Scholar]
  4. Evans G. H., Shand D. G. Disposition of propranolol. VI. Independent variation in steady-state circulating drug concentrations and half-life as a result of plasma drug binding in man. Clin Pharmacol Ther. 1973 Jul-Aug;14(4):494–500. doi: 10.1002/cpt1973144part1494. [DOI] [PubMed] [Google Scholar]
  5. Graham B. R., Littlejohns D. W., Prichard B. N., Scales B., Southorn P. Proceedings: Preliminary observations on the human pharmacology of I.C.I. 66082 in normal volunteers. Br J Pharmacol. 1973 Sep;49(1):154P–155P. [PMC free article] [PubMed] [Google Scholar]
  6. Hellenbrecht D., Lemmer B., Wiethold G., Grobecker H. Measurement of hydrophobicity, surface activity, local anaesthesia, and myocardial conduction velocity as quantitative parameters of the non-specific membrane affinity of nine -adrenergic blocking agents. Naunyn Schmiedebergs Arch Pharmacol. 1973;277(2):211–226. doi: 10.1007/BF00501161. [DOI] [PubMed] [Google Scholar]
  7. Korten K., Miller K. W. Erythrocyte ghost--buffer partition coefficients of phenobarbital, pentobarbital, and thiopental support the pH-partition hypothesis. Can J Physiol Pharmacol. 1979 Mar;57(3):325–328. doi: 10.1139/y79-050. [DOI] [PubMed] [Google Scholar]
  8. Pacha W. L. A method for the fluorimetric determination of 4-(2-hydroxy-3-isopropylaminopropoxy)-indole (LB46), a beta-blocking agent, in plasma and urine. Experientia. 1969 Aug 15;25(8):802–803. doi: 10.1007/BF01897885. [DOI] [PubMed] [Google Scholar]
  9. Pendleton R. G., Newman D. J., Sherman S. S., Brann E. G., Maya W. E. Effect of propranolol upon the hemoglobin-oxygen dissociation curve. J Pharmacol Exp Ther. 1972 Mar;180(3):647–656. [PubMed] [Google Scholar]
  10. Roth S., Seeman P. The membrane concentrations of neutral and positive anesthetics (alcohols, chlorpromazine, morphine) fit the Meyer-Overton rule of anesthesia; negative narcotics do not. Biochim Biophys Acta. 1972 Jan 17;255(1):207–219. doi: 10.1016/0005-2736(72)90023-5. [DOI] [PubMed] [Google Scholar]
  11. Shand D. G., Nuckolls E. M., Oates J. A. Plasma propranolol levels in adults with observations in four children. Clin Pharmacol Ther. 1970 Jan-Feb;11(1):112–120. doi: 10.1002/cpt1970111112. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES